By clicking "Allow," you will be taken to a website that is independent of ViiV Healthcare. The site you linking to is not controlled or endorsed by ViiV Healthcare, and ViiV Healthcare is not responsible for the content provided on that site.
This site is intended for US healthcare professionals only.
Cabenuva is a 2-drug co-packaged product of cabotegravir, a HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
External HCPs’ Opinions on Appropriate Selection of Patients for CABENUVA Treatment
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Dr. Rick Elion, MD - Washington Health Institute
Dr. Douglass Cunningham, DO - Pueblo Family Physicians
Dr. Cynthia Rivera, MD - Midway Specialty Care
SOLAR Data Overview with Providers Thoughts of the Data
Video Player is loading.
Current Time 0:00
/
Duration 7:26
Loaded: 0.00%
0:00
Stream Type LIVE
Remaining Time -7:26
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
SOLAR Data Overview with Providers’ Thoughts of the Data
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Post-CROI 2022 Webinar
Video Player is loading.
Current Time 0:00
/
Duration 34:42
Loaded: 0.29%
00:00
Stream Type LIVE
Remaining Time -34:42
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Cabenuva Post CROI 2022 Discussion
Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare
Mark Lewandowski, PharmD —Medical Director, ViiV Healthcare
Atlas 2M Week 152 Data - Discussion and Application to Clinical Practice
Video Player is loading.
Current Time 0:00
/
Duration 8:31
Loaded: 1.16%
0:00
Stream Type LIVE
Remaining Time -8:31
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir
Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, Cabotegravir
Video Player is loading.
Current Time 0:00
/
Duration 1:10:45
Loaded: 0.14%
0:00:00
Stream Type LIVE
Remaining Time -1:10:45
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice
Paula Teichner, PharmD, AAHIVP, Regional Medical Lead
ViiV Post CROI Webinar
Video Player is loading.
Current Time 0:00
/
Duration 1:29:17
Loaded: 0.11%
0:00:00
Stream Type LIVE
Remaining Time -1:29:17
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
SOLAR Data Overview with Providers Thoughts of the Data
Video Player is loading.
Current Time 0:00
/
Duration 7:26
Loaded: 0.00%
0:00
Stream Type LIVE
Remaining Time -7:26
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
SOLAR Data Overview with Providers’ Thoughts of the Data
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Discussing CABENUVA Data at AIDS 2022
Video Player is loading.
Current Time 0:00
/
Duration 5:06
Loaded: 1.94%
0:00
Stream Type LIVE
Remaining Time -5:06
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Discussing CABENUVA Data at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers
Post-CROI 2022 Webinar
Video Player is loading.
Current Time 0:00
/
Duration 34:42
Loaded: 0.29%
00:00
Stream Type LIVE
Remaining Time -34:42
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Cabenuva Post CROI 2022 Discussion
Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare
Mark Lewandowski, PharmD —Medical Director, ViiV Healthcare
Atlas 2M Week 152 Data - Discussion and Application to Clinical Practice
Video Player is loading.
Current Time 0:00
/
Duration 8:31
Loaded: 1.17%
0:00
Stream Type LIVE
Remaining Time -8:31
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir
Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, Cabotegravir
ViiV Post CROI Webinar
Video Player is loading.
Current Time 0:00
/
Duration 1:29:17
Loaded: 0.11%
0:00:00
Stream Type LIVE
Remaining Time -1:29:17
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
HCPs’ Impressions on the Impact of SOLAR data in their practice
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Dr. Rick Elion, MD - Washington Health Institute
Dr. Douglass Cunningham, DO - Pueblo Family Physicians
Dr. Cynthia Rivera, MD - Midway Specialty Care
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch
This site uses cookies and similar technologies (collectively, "cookies") to enhance your website experience and track the site's performance. These cookies are automatically enabled. By using this site, you agree to our use of these cookies in accordance with our Privacy Notice. Click on Privacy Choices below to manage your preferences, including to opt out of the sale or sharing of your information.
Managing Privacy Options
OPT OUT OF SALE AND SHARING OF INFORMATION
Your state law may allow you the right to opt out of the sale or sharing of your personal information for targeted advertising. You may opt out of such sale or share via the toggle available to you for "Targeting Cookies," and selecting the "Confirm my choices” button below. To limit sale or sharing of your information for targeting advertising offline, please see the "Cookies and Targeted Advertising Choices," section in the Privacy Notice and submit the required form.
Always Active
Necessary for the website to function appropriately, such as to store session data during a website visit, to manage cookie and tag preferences, and to protect the security of the website. In addition, some of these cookies are set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms.
Always Active
Enable the website to provide enhanced functionality and personalization, such as by helping us to measure how many visitors come to our websites, what sites our website visitors come from, and how often certain pages on our website are viewed. These cookies may be set by us or by third party providers, like our analytics service providers, whose services we have added to our pages.
Allow us to target and re-target you with relevant advertising. We and our advertising partners use information collected through these technologies to infer your interests in order to serve you more relevant advertisements on other sites. If you don’t allow these cookies, you will receive advertising, but it may be less relevant to you.
